anti-programmed cell death-1 antibody (Merck & Co)

N/A

Report date: 2025/03/14 20:00:48

Base Information

Drug Nameanti-programmed cell death-1 antibody (Merck & Co)
Drug Alias Nameanti-PD-1 antibody (Merck & Co)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionProgrammed death-ligand 1 blockers
TargetsProgrammed death-ligand 1
Therapy Area/IndicationsNeoplasmsVirus Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMerck Research Laboratories
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMerck Research Laboratories
Active IndicationsN/A
Inactive IndicationsNeoplasmsVirus Diseases

Other Information

ATC CodeN/A
Related LinksN/A